Table 3.
Preterm < 37 weeks (n=21) | Preterm < 37 weeks (n=27) | Preterm < 37 weeks (n=67) | ||||
---|---|---|---|---|---|---|
+ + |
Malperfusion Other lesions† |
+ − |
Malperfusion Other lesions† |
− + |
Malperfusion Other lesions† |
|
| ||||||
difference (se) | p* | difference (se) | p* | difference (se) | p* | |
Unadjusted | 0.060 (.02) | 0.002 | 0.013 (.02) | 0.442 | 0.020 (.01) | 0.081 |
Model 1, adjusted for pre-pregnancy features and time (race, age, pre-pregnancy BMI, smoking, and years to study visit) | 0.037 (.02) | 0.031 | −0.003 (.02) | 0.839 | 0.015 (.01) | 0.126 |
Model 2, additionally adjusted for intermediates (SBP, apolipoprotein B, smoking) | 0.027 (.02) | 0.095 | −0.009 (.01) | 0.541 | 0.009 (.01) | 0.376 |
Referent for all models is women with term births. Intermediates (systolic blood pressure [SBP], smoking, and apolipoprotein B [mg/dl]) measured at the cardiovascular screening visit 4–12 years after delivery
Other lesions include AIUI (n=30), villitis (n=6), fetal thrombosis (n=20), chorangiosis (n=9); Women with preterm birth and no lesions excluded (n=1)